Published in
Elsevier, Annals of Oncology, (32), p. S1015-S1016, 2021
DOI: 10.1016/j.annonc.2021.08.1926
Links
Tools
1325P Checkpoint inhibitor monotherapy in potentially study-eligible or non-study-eligible NSCLC patients in the German CRISP registry real-world cohort (AIO-TRK-0315)
Journal article published in 2021 by
F. Griesinger,
M. Sebastian,
W. Brückl,
H.-D. Hummel,
B. Jaeschke,
J. Kern,
C. Schumann,
C. Wesseler 
,
M. Jänicke,
A. Fleitz,
S. Zacharias,
A. Hipper,
A. Groth,
W. Weichert,
S. Dörfel
and other authors.
,
M. Jänicke,
A. Fleitz,
S. Zacharias,
A. Hipper,
A. Groth,
W. Weichert,
S. Dörfel
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 